Israel Innovation Authority רשות החדשנות
Roni Wechsler is an accomplished professional with extensive experience in research and development within the life sciences sector. Currently serving as VP of Research at Moebius Medical Ltd. and an evaluator at the Israel Innovation Authority, Roni has held significant roles including VP Research & Development at Regentis Biomaterials Ltd., and CTO at both ProCore Biomed and ProChon Biotech. With a robust academic background, Roni holds a Ph.D. in Neurobiology and an MBA focused on BioMedical from the Weizmann Institute of Science and The College of Management Academic Studies, respectively, alongside earlier degrees in Biology and Biochemistry from Weizmann Institute of Science and McGill University.
This person is not in any offices
Israel Innovation Authority רשות החדשנות
The Israel Innovation Authority is Israel's central agency to manage the country’s governmental support of the resource of innovation. As the governments' operational arm in the arena of technological innovation and R&D, the goal of the Authority is to provide professional support and infrastructure to government efforts to encourage innovation in all industry sectors, complementing the major role that Israel already plays in the global high-tech sector. The Israel Innovation Authority has three main roles: creating infrastructure to support diverse industries, developing tools and programs that suit the needs of the industry, and budgeting and financing high-risk projects and products. In addition to these roles, the Authority serves as a central hub for knowledge and consists of six customer-oriented “Innovation Divisions,” each providing a variety of tools for each market segment and stage in the life cycle of a product: Technological Infrastructure, Advanced Manufacturing, International Collaborations, Societal Challenges, Growth and Early Stage.